HE; Chengxi
Patent Applications and Registrations
Patent applications and USPTO patent grants for HE; Chengxi.The latest application filed is for "substituted imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine compounds as ret kinase inhibitors".
- HE; Chengxi - Chongqing CN
- HE; Chengxi - Nan'an District Chongqing
| Patent | Date |
|---|---|
| Substituted Imidazo[1,2-a]pyridine And [1,2,4]triazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20220041588 - HE; Chengxi ; et al. | 2022-02-10 |
| Apoptosis-inducing agents Grant 11,091,478 - Liu , et al. August 17, 2 | 2021-08-17 |
| Compounds as BLC-2-selective apoptosis-inducing agents Grant 11,053,239 - Zhao , et al. July 6, 2 | 2021-07-06 |
| Macrocyclic Compounds As Trk Kinases Inhibitors App 20210139506 - ZHANG; Huajie ; et al. | 2021-05-13 |
| SUBSTITUTED (2-AZABICYCLO[3.1.0]HEXAN-2-YL)PYRAZOLO[1,5-a]PYRIMIDINE AND IMIDAZO[1,2-b]PYRIDAZINE COMPOUNDS AS TRK KINASES INHIBITORS App 20210024528 - LIU; Hongbin ; et al. | 2021-01-28 |
| Apoptosis-inducing Agents App 20200115379 - LIU; Hongbin ; et al. | 2020-04-16 |
| Compounds As Bcl-2-selective Apoptosis-inducing Agents App 20190345156 - ZHAO; Xingdong ; et al. | 2019-11-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 